GLP-1 pill: Eli Lilly says its oral orforglipron showing "promising results" – Axios
Business News
- GLP-1 pill: Eli Lilly says its oral orforglipron showing “promising results” Axios
- Daily Pill May Work as Well as Ozempic for Weight Loss and Blood Sugar The New York Times
- Lilly’s oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial Eli Lilly and Company
- Eli Lilly’s weight loss pill succeeds in first late-stage trial on diabetes patients; shares jump 14% CNBC
- How a New Weight-Loss Pill Could Transform Health Time Magazine
Source: Business News